BG Medicine (BGMD) Reports In-Line Q3 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq ends lower as oil prices surge ahead of earnings, economic data
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
- One dead in new attack on Saudi airport, a day after Houthi strike kills 13
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Lumentum shares fall after hitting 52-week high
Ladenburg Thalmann Downgrades BG Medicine (BGMD) to Neutral
November 13, 2014 11:22 AM ESTLadenburg Thalmann downgraded BG Medicine (NASDAQ: BGMD) from Buy to Neutral.
For an analyst ratings summary and ratings history on BG Medicine click here. For more ratings news on BG Medicine click here.
Shares of BG Medicine closed at $0.47 yesterday.
... More


